NCT00273026终止4 期
An Open-label, Multi-centre, Randomized, Parallel Group Clinical Effectiveness Study to Determine the Level of Asthma Control in Adolescent and Adult Patients With ADVAIR Versus Usual Care for 24 Weeks.
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 终止
- 入组人数
- 680
- 试验地点
- 133
- 主要终点
- Percentage of patients achieving well-controlled asthma at the end of the treatment period.
研究概览
简要总结
This study will compare patients treated with a marketed medication and those who continue with their usual care to assess the proportion of patients achieving well controlled asthma after 24 weeks.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 12 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •documented clinical history of asthma and receiving regular maintenance therapy.
排除标准
- •Using oral/parenteral or depot corticosteroids within 12 weeks of visit
- •History of heavy smoking or substance abuse.
- •Females who are pregnant or lactating.
- •Required emergency room treatment for their asthma 12 weeks prior to Visit
- •Serious, uncontrolled, systemic disease that may make study participation unsafe or inappropriate in the opinion of the physician.
- •Other medical criteria will be evaluated at the screening visit.
结局指标
主要结局
Percentage of patients achieving well-controlled asthma at the end of the treatment period.
次要结局
- Percentage of patients achieving total asthma control as defined by the Canadian Asthma consensus guidelines at the end of the treatment period.
研究者
研究点 (133)
Loading locations...
相似试验
已完成
不适用
Clinical Performance and Safety Comparison of Stay Safe Link® With Stay Safe® in Patient on CAPD (CAPD-3)Continuous Ambulatory Peritoneal DialysisNCT03177031Penang Hospital, Malaysia472
已完成
3 期
A Study Comparing Maintenance Subcutaneous Rituximab With Observation Only in Participants With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma Who Had Responded to Rituximab-based Immunochemotherapy Induction and 2-year Maintenance With Subcutaneous RituximabNon-Hodgkin's LymphomaNCT01461928Hoffmann-La Roche692
终止
4 期
A Study Comparing Safety and Efficacy of Levofloxacin and Metronidazole Versus Piperacillin/Tazobactam in Treating Complicated AppendicitisAppendicitisNCT00236912Johnson & Johnson Pharmaceutical Research & Development, L.L.C.139
已完成
3 期
Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive AdultsSmall Cell Lung CancerNCT00043927GlaxoSmithKline760
已完成
1 期
A Study to Compare the PK, PD and Safety and Tolerability of a SC With an IV Formulation of ARGX-113 in Healthy Male SubjectsBioavailability StudyNCT03334084argenx40